Kyoko Matsuguma

Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease

Kyoko Matsuguma, Seiji Ueda, Sho‐ichi Yamagishi et al. · Journal of the American Society of Nephrology · 2006 · 157 citations

Medicine, Biochemistry, Nephrology +14

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

Yukio Horai, Masahiko Kimura, Hidetoshi Furuie et al. · Alimentary Pharmacology & Therapeutics · 2001 · 118 citations

Medicine, Pharmacokinetics, Pharmacology +14

Dimethylarginine Dimethylaminohydrolase Prevents Progression of Renal Dysfunction by Inhibiting Loss of Peritubular Capillaries and Tubulointerstitial Fibrosis in a Rat Model of Chronic Kidney Disease

Yuriko Matsumoto, Seiji Ueda, Sho‐ichi Yamagishi et al. · Journal of the American Society of Nephrology · 2007 · 106 citations

Medicine, Pathology, Pharmacology +11

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes

Tadahiro Shinozawa, Koki Nakamura, Masanobu Shoji et al. · Stem Cell Reports · 2017 · 64 citations · Full text

Medicine, Pharmacology, Translational Sciences +13

BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides

Kei Sakamoto, Shunji Matsuki, Kyoko Matsuguma et al. · The Journal of Clinical Pharmacology · 2017 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +17